Work

Vaccine immunotherapy with MVA-Muc1-IL2 (TG4010) in prostate cancer patients with biochemical failure

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.4518

Authors: R. Dreicer, R. Ahman, A. Pantuck, W. M. Stadler, N. Bizouarne, B. Acres, A. Derbij, J.-M. Limacher, P. Squiban

Institutions: Cleveland Clinic, University of California, Los Angeles, University of Chicago

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2278250224

Cites:

Cited by: 14

Related to: 10